These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 8721862)

  • 41. Primary lysis of eosinophils in severe desquamative asthma.
    Persson C
    Clin Exp Allergy; 2014 Feb; 44(2):173-83. PubMed ID: 24330324
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Eosinophil degranulation is more important than eosinophilia in identifying asthma in chronic cough.
    Kim CK; Callaway Z; Kim DW; Kita H
    J Asthma; 2011 Dec; 48(10):994-1000. PubMed ID: 22022864
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Airway hyperresponsiveness, peak flow variability and inflammatory markers in non-asthmatic subjects with respiratory infections.
    Björnsson E; Lúdvíksdóttir D; Hedenström H; Eriksson BM; Högman M; Venge P; Janson C
    Clin Respir J; 2007 Jul; 1(1):42-50. PubMed ID: 20298277
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Burden of asthma with elevated blood eosinophil levels.
    Casciano J; Krishnan JA; Small MB; Buck PO; Gopalan G; Li C; Kemp R; Dotiwala Z
    BMC Pulm Med; 2016 Jul; 16(1):100. PubMed ID: 27412347
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Nitric oxide metabolites, eosinophils, and eosinophilic cationic protein in patients with asthma: sputum versus blood.
    Jang AS; Yeum CH; Choi IS
    J Korean Med Sci; 2003 Aug; 18(4):489-93. PubMed ID: 12923323
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Exhaled NO and eosinophil markers in blood, nasal lavage and sputum in children with asthma after withdrawal of budesonide.
    Lönnkvist K; Anderson M; Hedlin G; Svartengren M
    Pediatr Allergy Immunol; 2004 Aug; 15(4):351-8. PubMed ID: 15305945
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Expression of the apoptosis inhibitor Bcl-2 in sputum eosinophils from children with acute asthma.
    El-Gamal Y; Heshmat N; Mahran M; El-Gabbas Z
    Clin Exp Allergy; 2004 Nov; 34(11):1701-6. PubMed ID: 15544593
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Eosinophils in asthma.
    Busse WW; Sedgwick JB
    Ann Allergy; 1992 Mar; 68(3):286-90. PubMed ID: 1546825
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pranlukast, a cysteinyl leukotriene antagonist, reduces serum eosinophil cationic protein levels in patients with asthma.
    Ishioka S; Hozawa S; Haruta Y; Hiyama K; Maeda A; Yamakido M
    Hiroshima J Med Sci; 1999 Dec; 48(4):105-10. PubMed ID: 10804983
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The platelet in asthma.
    Slater D; Martin J; Trowbridge A
    Lancet; 1985 Jan; 1(8420):110. PubMed ID: 2857009
    [No Abstract]   [Full Text] [Related]  

  • 51. Eosinopenia in status asthmaticus; a report of two cases.
    JENNINGS PB
    J Med Soc N J; 1951 Nov; 48(11):507-9. PubMed ID: 14880862
    [No Abstract]   [Full Text] [Related]  

  • 52. Children's ability to identify bronchial obstruction.
    Linna O
    Acta Paediatr; 1994 Jun; 83(6):662-3. PubMed ID: 7919767
    [No Abstract]   [Full Text] [Related]  

  • 53. [Why isn't there more controversy on long-acting beta2-agonists in asthma?].
    Boussageon R
    Rev Mal Respir; 2011 Oct; 28(8):1079-80; author reply 1080. PubMed ID: 22099413
    [No Abstract]   [Full Text] [Related]  

  • 54. The enigma of the eosinophil.
    Beeson PB
    West J Med; 1982 Sep; 137(3):239-40. PubMed ID: 18749203
    [No Abstract]   [Full Text] [Related]  

  • 55. [Eosinophil activation markers in status asthmaticus].
    Nagy L; Süttö Z; Tolnay E; Terék K; Orosz M; Szentpály O
    Orv Hetil; 1996 Jan; 137(3):121-4. PubMed ID: 8721862
    [TBL] [Abstract][Full Text] [Related]  

  • 56.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 3.